AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Deciphera PharmaceuticalsArrowhead PharmaceuticalsAmicus TherapeuticsAllakosPTC Therapeutics
SymbolNASDAQ:DCPHNASDAQ:ARWRNASDAQ:FOLDNASDAQ:ALLKNASDAQ:PTCT
Price Information
Current Price$56.80$45.25$15.78$68.86$57.07
52 Week RangeBuyBuyBuyHoldBuy
Beat the Market™ Rank
Overall Score1.51.41.61.11.1
Analysis Score3.43.44.41.02.3
Community Score2.52.53.02.32.5
Dividend Score0.00.00.00.00.0
Ownership Score1.01.00.02.00.0
Earnings & Valuation Score0.60.00.60.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$68.31$62.00$20.31$65.00$62.83
% Upside from Price Target20.27% upside37.02% upside28.72% upside-5.61% downside10.10% upside
Trade Information
Market Cap$3.08 billion$4.58 billion$4.10 billion$3.24 billion$3.54 billion
Beta2.181.811.3511.4
Average Volume583,3651,500,3383,349,104365,928839,014
Sales & Book Value
Annual Revenue$25 million$168.80 million$182.24 millionN/A$306.98 million
Price / Sales126.9127.2822.31N/A12.17
CashflowN/A$0.80 per shareN/AN/AN/A
Price / CashN/A56.41N/AN/AN/A
Book Value$10.71 per share$2.57 per share$1.87 per share$10.19 per share$9.64 per share
Price / Book5.3017.618.44N/A5.92
Profitability
Net Income$-192,260,000.00$67.97 million$-356,390,000.00$-85,370,000.00$-251,580,000.00
EPS($4.48)$0.69($1.31)($1.89)($3.45)
Trailing P/E RatioN/A502.83N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A6.86%-155.73%N/A-90.83%
Return on Equity (ROE)-42.53%2.61%-63.24%-22.74%-46.42%
Return on Assets (ROA)-38.44%2.08%-37.83%-21.66%-17.31%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.02%0.03%0.50%N/A0.56%
Current Ratio15.61%5.90%4.45%33.75%3.18%
Quick Ratio15.61%5.90%4.31%33.75%3.09%
Ownership Information
Institutional Ownership Percentage71.97%64.26%N/A69.43%N/A
Insider Ownership Percentage3.81%4.00%2.30%44.77%7.00%
Miscellaneous
Employees11211650862511
Shares Outstanding55.86 million101.77 million257.66 million48.77 million65.48 million
Next Earnings Date8/7/2020 (Estimated)8/3/2020 (Estimated)8/13/2020 (Estimated)8/3/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.